Morgan Stanley Finance LLC Files New Securities Prospectus
| Field | Detail |
|---|---|
| Company | Morgan Stanley Finance LLC |
| Form Type | 424B2 |
| Filed Date | Mar 24, 2026 |
| Risk Level | medium |
| Pages | 16 |
| Reading Time | 19 min |
| Key Dollar Amounts | $1,000, $976.30, $35.00, $1,271.50, $1,060 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: debt-offering, prospectus, capital-raise
Related Tickers: MS
TL;DR
**Morgan Stanley Finance LLC is prepping a new securities offering, watch for details on terms and potential dilution.**
AI Summary
Morgan Stanley Finance LLC filed a 424B2 prospectus on March 24, 2026, for a new offering under its parent company, Morgan Stanley. This filing, specifically Preliminary Pricing Supplement No. 15,134, indicates that Morgan Stanley Finance LLC is preparing to issue new securities. For investors, this means Morgan Stanley Finance LLC is likely raising capital, which could impact its financial leverage and future earnings, potentially affecting the stock's valuation depending on the terms of the offering.
Why It Matters
This filing signals Morgan Stanley Finance LLC's intent to issue new securities, which could dilute existing shareholders or increase the company's debt obligations, impacting its financial health.
Risk Assessment
Risk Level: medium — The filing itself is a standard procedural step, but the underlying offering could introduce new financial risks or opportunities depending on its structure and size.
Analyst Insight
Investors should monitor subsequent filings (like a final pricing supplement) to understand the specific terms, size, and impact of the new securities offering on Morgan Stanley Finance LLC's financial structure and potential returns.
Key Numbers
- 0001666268 — CIK for Morgan Stanley Finance LLC (Unique identifier for the filing entity)
- 0000895421 — CIK for Morgan Stanley (Unique identifier for the parent company)
- 2026-03-24 — Filing Date (Date the 424B2 was filed and accepted)
- 15,134 — Pricing Supplement Number (Identifies the specific preliminary pricing supplement)
- 333-275587 — Act File Number (Registration statement under which the offering is made)
Key Players & Entities
- Morgan Stanley Finance LLC (company) — Filer of the 424B2 prospectus
- Morgan Stanley (company) — Parent company of Morgan Stanley Finance LLC
- March 24, 2026 (date) — Filing date of the 424B2
- Preliminary Pricing Supplement No. 15,134 (document) — Specific document within the 424B2 filing
- 333-275587-01 (document) — File number for Morgan Stanley Finance LLC's offering
Forward-Looking Statements
- Morgan Stanley Finance LLC will issue new securities within the next few months. (Morgan Stanley Finance LLC) — high confidence, target: 2026-09-24
FAQ
What is the purpose of this 424B2 filing by Morgan Stanley Finance LLC?
The 424B2 filing, specifically 'PRELIMINARY PRICING SUPPLEMENT NO. 15,134', indicates that Morgan Stanley Finance LLC is preparing to offer new securities under its existing shelf registration statement (File No. 333-275587-01).
When was this 424B2 filing submitted and accepted by the SEC?
The filing was submitted and accepted on March 24, 2026, at 13:41:13, according to the SEC Accession No. 0001839882-26-016680.
Who is the parent company of Morgan Stanley Finance LLC, and what is its CIK?
The parent company is Morgan Stanley, with CIK 0000895421, as indicated in the filing details.
What type of business does Morgan Stanley Finance LLC primarily engage in, according to its SIC code?
Morgan Stanley Finance LLC's SIC code is 6189, which corresponds to 'Asset-Backed Securities', as stated in the filing.
What is the specific document within this filing that provides details about the new offering?
The specific document is 'PRELIMINARY PRICING SUPPLEMENT NO. 15,134', which is listed as Document Type 424B2 and has a size of 213409 bytes.
Filing Stats: 4,746 words · 19 min read · ~16 pages · Grade level 15.7 · Accepted 2026-03-24 13:41:13
Key Financial Figures
- $1,000 — an Stanley Stated principal amount: $1,000 per security Issue price: $1,000 pe
- $976.30 — ue on the pricing date: Approximately $976.30 per security, or within $35.00 of that
- $35.00 — imately $976.30 per security, or within $35.00 of that estimate. See "Estimated Value
- $1,271.50 — erlier Maximum payment at maturity: $1,271.50 per security (127.15% of the stated pri
- $1,060 — appreciates 5%, investors will receive $1,060 per security, or 106% of the stated pri
- $200 — 80% of their principal and receive only $200 per security at maturity, or 20% of the
Filing Documents
- ms15134_424b2-10764.htm (424B2) — 208KB
- image1.gif (GRAPHIC) — 34KB
- image2.gif (GRAPHIC) — 83KB
- image3.gif (GRAPHIC) — 78KB
- 0001839882-26-016680.txt ( ) — 479KB
Risk Factors
Risk Factors This section describes the material risks relating to the securities. For further discussion of these and other risks, you should read the section entitled "Risk Factors" in the accompanying product supplement and prospectus. We also urge you to consult with your investment, legal, tax, accounting and other advisers in connection with your investment in the securities. Risks Relating to an Investment in the Securities The securities provide for only the minimum payment at maturity and do not pay interest. The terms of the securities differ from those of ordinary debt securities in that they provide for only the minimum payment at maturity and do not pay interest. If the final level of either underlier is less than its buffer level, the payout at maturity will be an amount in cash that is less than the stated principal amount of each security, and you will lose an amount proportionate to the full decline in the level of the worst performing underlier over the term of the securities beyond the buffer amount . You could lose a significant portion of your initial investment in the securities. The appreciation potential of the securities is limited by the maximum payment at maturity. Where the final level of the worst performing underlier is greater than its initial level, the appreciation potential of the securities is limited by the maximum payment at maturity. Although the leverage factor provides enhanced exposure to any increase in the final level of the worst performing underlier over its initial level, if the worst performing underlier appreciates over the term of the securities, under no circumstances will the payment at maturity exceed the maximum payment at maturity. The amount payable on the securities is not linked to the values of the underliers at any time other than the observation date. The final levels will be based on the closing levels of the underliers on the observation date, subject to postponement for non-trading days and cer